From Yahoo Finance: 2025-03-22 11:05:00

Investors are overlooking three promising growth stocks that have not yet hinted at a recovery post-market correction. PepsiCo’s stock is down 25% from its peak due to inflation issues, but its dividend yield and ownership structure make it a solid investment. Iovance Biotherapeutics, a biopharma company, has promising cancer therapies and strong revenue growth projections. Sirius XM Holdings is revamping its strategies, with potential for growth despite past lackluster performance.

Iovance Biotherapeutics has seen its stock drop more than 90% from its high due to market overreaction. Despite promising cancer therapies and strong revenue growth, investors are concerned about the lack of earnings. Sirius XM Holdings is making strategic moves into streaming radio and advertising, but its stock price remains low.

Consider investing in overlooked stocks like PepsiCo, Iovance Biotherapeutics, and Sirius XM Holdings for potential long-term gains. While the market may have overlooked them, their growth prospects and innovative strategies make them worthwhile investments. Don’t miss out on these opportunities for future returns.

Read more: 3 Growth Stocks Wall Street Might Be Sleeping On — But I’m Not